/

MBX Biosciences

Develops precision peptide therapies for endocrine and metabolic disorders

BiotechnologyPharmaceuticals mbxbio.com ↗

Company facts

Founded: 2018
Employees: 48
Headquarters: United States
Type: Public
Listed: NASDAQ: MBX